Your browser doesn't support javascript.
loading
Precision gestational diabetes treatment: a systematic review and meta-analyses.
Benham, Jamie L; Gingras, Véronique; McLennan, Niamh-Maire; Most, Jasper; Yamamoto, Jennifer M; Aiken, Catherine E; Ozanne, Susan E; Reynolds, Rebecca M.
Affiliation
  • Benham JL; Department of Medicine and Community Health Sciences, Cumming School of Medicine, University of Calgary, Calgary, AB, Canada.
  • Gingras V; Department of Nutrition, Université de Montréal, Montreal, QC, Canada.
  • McLennan NM; Research Center, Sainte-Justine University Hospital Center, Montreal, QC, Canada.
  • Most J; MRC Centre for Reproductive Health, Queens's Medical Research Institute, University of Edinburgh, Edinburgh, UK.
  • Yamamoto JM; Centre for Cardiovascular Science, Queens's Medical Research Institute, University of Edinburgh, Edinburgh, UK.
  • Aiken CE; Department of Orthopedics, Zuyderland Medical Center, Sittard-Geleen, The Netherlands.
  • Ozanne SE; Internal Medicine, University of Manitoba, Winnipeg, MB, Canada.
  • Reynolds RM; Department of Obstetrics and Gynaecology, the Rosie Hospital, Cambridge, UK.
Commun Med (Lond) ; 3(1): 135, 2023 Oct 05.
Article in En | MEDLINE | ID: mdl-37794196
Gestational diabetes (GDM) is high blood sugar first detected during pregnancy. Normalizing blood sugar levels quickly is important to avoid pregnancy complications. Many women achieve this with lifestyle changes, such as to diet, but some need to inject insulin or take tablets. We did two thorough reviews of existing research to see if we could predict which women need medication. Firstly we looked for ways to identify the characteristics of women who benefit most from changing their lifestyles to treat GDM, but found very limited research on this topic. We secondly searched for characteristics that help identify women who need medication to treat GDM. We found some useful characteristics that are obtained during routine pregnancy care. Further studies are needed to test if additional information could provide even better information about how we could make GDM treatment more tailored for individuals during pregnancy.

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Guideline / Prognostic_studies / Systematic_reviews Language: En Journal: Commun Med (Lond) Year: 2023 Type: Article Affiliation country: Canada

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Guideline / Prognostic_studies / Systematic_reviews Language: En Journal: Commun Med (Lond) Year: 2023 Type: Article Affiliation country: Canada